|
DRG 181: RESPIRATORY NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) |
DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations at DRG |
37,484 |
|
|
Total Hospitalizations with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
30 |
|
|
DRG Share of Total Hospitalizations |
0.11 |
|
|
% of Total ICD G731 - Lambert-Eaton syndrome in neoplastic disease in DRG |
11.07 |
|
|
Avg LOS at DRG |
4.49 |
|
|
Avg LOS with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
8.93 |
|
|
Readmission Rate at DRG |
27.89 |
|
|
Readmission Rate with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
NA |
|
|
Unplanned Readmission Rate at DRG |
21.07 |
|
|
Unplanned Readmission Rate with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
NA |
|
|
Total Medicare payments at DRG |
$287,773,529 |
|
|
Total Medicare payments with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
$301,925 |
|
|
Total Medicare payment per Day at DRG |
$1,709 |
|
|
Total Medicare payment per Day with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
$1,127 |
|
|
Total Medicare payment per Hospitalization at DRG |
$7,677 |
|
|
Total Medicare payment per Hospitalization with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
$10,064 |
|
|
Total Medicare Charges at DRG |
$1,483,578,942 |
|
|
Total Medicare Charges with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
$2,548,725 |
|
|
Avg Charges at DRG |
$39,579 |
|
|
Avg Charges with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
$84,958 |
|
|
Mortality Rate at DRG |
4.3 |
|
|
Mortality Rate with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
NA |
|
|
SNF Discharge Rate at DRG |
10.7 |
|
|
SNF Discharge Rate with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
NA |
|
|
Home Discharge Rate at DRG |
44.82 |
|
|
Home Discharge Rate with ICD G731 - Lambert-Eaton syndrome in neoplastic disease |
NA |
|
|